Latest On TRACON Pharmaceuticals, Inc (TCON):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-11 11:08 EST | News | TRACON Pharmaceuticals, Inc. (TCON) Q1 2023 Earnings Call Transcript | N/A |  |
| 2023-05-10 21:08 EST | News | Tracon GAAP EPS of -$0.36 misses by $0.09 | N/A | |
| 2023-05-09 18:52 EST | News | Tracon Q1 2023 Earnings Preview | N/A | |
| 2023-04-25 10:01 EST | News | Tracon stock slumps ~15% after I-Mab gets favorable ruling in arbitration | N/A | |
| 2023-03-10 14:11 EST | News | Tracon to offer $3M worth of securities in private placement | N/A | |
| 2023-03-09 07:20 EST | News | TRACON Pharmaceuticals, Inc. (TCON) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-03-08 16:37 EST | News | Tracon GAAP EPS of -$0.31 in-line | N/A | |
| 2022-12-27 12:42 EST | News | TRACON Pharmaceuticals announced $30M attributed to award decision expected in Q1 2023 | N/A | |
| 2022-12-14 23:33 EST | News | Tracon Pharma announces positive results from phase 2 trial of Envafolimab | N/A | |
| 2022-11-30 06:54 EST | News | Revisiting Tracon Pharmaceuticals | N/A | |
| 2022-11-15 08:35 EST | News | TRACON Pharmaceuticals, Inc. (TCON) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-15 08:35 EST | News | Tracon GAAP EPS of -$0.30 beats by $0.02 | N/A | |
| 2022-11-13 23:29 EST | News | Tracon Q3 2022 Earnings Preview | N/A | |
| 2022-09-14 11:32 EST | News | Tracon wins FDA’s fast track status for connective tissue tumor candidate | N/A | |
| 2022-09-06 15:42 EST | News | Tracon Pharmaceuticals announces $35M non-dilutive debt facility | N/A | |
| 2022-08-29 19:06 EST | News | Tracon Pharma gets FDA nod to start phase 1/2 trial of triplet combo to treat sarcoma | N/A | |
| 2022-08-11 00:16 EST | News | Tracon GAAP EPS of -$0.31 beats by $0.05, revenue of $0M | N/A | |
| 2022-08-11 00:15 EST | News | TRACON Pharmaceuticals, Inc. (TCON) CEO Charles Theuer on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-10 06:18 EST | News | Tracon Q2 2022 Earnings Preview | N/A | |
| 2022-05-12 05:27 EST | News | Tracon GAAP EPS of -$0.48 misses by $0.06 | N/A | |
| 2022-05-12 05:27 EST | News | TRACON Pharmaceuticals, Inc. (TCON) CEO Charles Theuer on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-11 11:00 EST | News | Tracon Q1 2022 Earnings Preview | N/A | |
| 2022-04-19 11:36 EST | News | TRACON Pharma says amended protocol for ENVASARC trial approved at all 30 clinical sites | N/A | |
| 2022-03-22 04:41 EST | News | TRACON Pharmaceuticals, Inc. 2021 Q4 - Results - Earnings Call Presentation | N/A | |
| 2022-03-16 13:02 EST | News | Tracon GAAP EPS of -$0.40 misses by $0.04 | N/A | |
| 2022-03-16 13:01 EST | News | TRACON Pharmaceuticals, Inc. (TCON) CEO Charles Theuer on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-03-15 10:13 EST | News | Tracon Pharmaceuticals Q4 2021 Earnings Preview | N/A | |
| 2021-12-27 20:51 EST | News | Tracon Pharma drops 9% despite 'positive' envafolimab results from ENVASARC trial | N/A | |
| 2021-11-29 15:54 EST | News | Tracon Pharma stock jumps 13% on regulatory approval of envafolimab in China | N/A | |
| 2021-11-04 17:18 EST | News | TRACON Pharmaceuticals, Inc. (TCON) CEO Charles Theuer on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-03 19:51 EST | News | Tracon EPS misses by $0.05 | N/A | |
| 2021-11-03 00:16 EST | News | Tracon Q3 2021 Earnings Preview | N/A | |
| 2021-10-11 18:17 EST | News | TRACON and Eucure Biopharma ink development agreement for YH001 | N/A | |
| 2021-08-12 04:47 EST | News | Tracon EPS misses by $0.27 | N/A | |
| 2021-08-12 04:47 EST | News | TRACON Pharmaceuticals (TCON) CEO Charles Theuer on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-07-22 03:51 EST | News | TRACON gets positive Independent Data Monitoring Committee recommendation for envafolimab trial | N/A | |
| 2021-07-22 03:47 EST | News | TRACON posts promising data from early-stage uliledlimab combo cancer trial | N/A | |
| 2021-07-22 03:30 EST | News | TRACON gets Orphan Drug status for envafolimab in soft tissue sarcoma | N/A | |
| 2021-07-22 03:04 EST | News | TRACON slumps 18% on $10M capital raise | N/A | |
| 2021-07-22 03:04 EST | News | TRACON Pharma secures $15M capital raise | N/A | |
| 2021-05-06 20:04 EST | News | TRACON Pharmaceuticals (TCON) CEO Charles Theuer on Q1 2021 Results - Earnings Call Transcript | N/A | |
| 2021-05-06 00:11 EST | News | Tracon EPS misses by $0.03 | N/A | |
| 2021-03-19 03:16 EST | News | TRACON Pharmaceuticals (TCON) Investor Presentation - Slideshow | N/A | |
| 2021-03-02 00:53 EST | Analyst Rating | The Analyst Target Price has increased from $13.38 to $14.75. | Buy | |
| 2021-03-01 12:26 EST | Analyst Rating | The Analyst Target Price has increased from $12.88 to $13.38. | Buy | |
| 2021-02-28 12:09 EST | News | Taking A Gander At Tracon Pharmaceuticals | N/A | |
| 2021-02-27 19:41 EST | News | TRACON Pharmaceuticals, Inc. (TCON) CEO Charles Theuer on Q4 2020 Results - Earnings Call Transcript | N/A | |
| 2021-02-26 16:26 EST | Financials | Company financials have been released. | Neutral | |
| 2021-02-26 07:58 EST | News | Tracon EPS beats by $0.10 | N/A | |
| 2021-02-26 04:47 EST | Earnings Estimate | An EPS average of -$0.30 is estimated for the quarter ending on June 30, 2021. | Buy | |
About TRACON Pharmaceuticals, Inc (TCON):
TRACON Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for cancer and age-related macular degeneration and fibrotic diseases in the United States. Its lead clinical stage product include envafolimab (KN035), an investigational PD-L1 single-domain antibody for the treatment of soft tissue sarcoma. The company's clinical stage products also include TRC102, which is a small molecule that is in Phase II clinical trial for the treatment of mesothelioma, Phase I clinical trial to treat solid tumors, Phase I to treat solid tumors and lymphomas, and Phase I trial to treat lung cancer; TRC253, a small molecule, which is in Phase II clinical trial for the treatment of metastatic castration-resistant prostate cancer; and TJ004309, a CD73 antibody that is in Phase I clinical development for the treatment of solid tumors. It has collaboration and license agreements with 3D Medicines Co., Ltd. and Jiangsu Alphamab Biopharmaceuticals Co., Ltd. for the development of envafolimab; I-Mab Biopharma for the development of CD73 antibody TJ004309; Janssen Pharmaceutica N.V. for the development of TRC253; Case Western Reserve University for the development of TRC102; and cooperative research and development agreement with National Cancer Institute. The company was formerly known as Lexington Pharmaceuticals, Inc. and changed its name to TRACON Pharmaceuticals, Inc. in March 2005. TRACON Pharmaceuticals, Inc. was incorporated in 2004 and is headquartered in San Diego, California.
General
- Name TRACON Pharmaceuticals, Inc
- Symbol TCON
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 18
- Last Split Factor1:10
- Last Split Date2019-11-08
- Fiscal Year EndDecember
- IPO Date2015-01-30
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.traconpharma.com
View More
Valuation
- Price/Book (Most Recent Quarter) 5.53
- Enterprise Value EBITDA 0.02
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$1.31
- Next Year EPS Estimate -$1.46
- Next Quarter EPS Estimate -$0.30
- Return on Assets -37%
- Return on Equity -121%
- Earnings Per Share -$1.02
- Revenue Per Share $0
- Gross Profit -8198000
- Quarterly Earnings Growth 0%
View More
Highlights
- Market Capitalization 142.87 million
- EBITDA -30190000
- Analyst Target Price $14.75
- Book Value Per Share $1.62
View More
Share Statistics
- Shares Outstanding 15.48 million
- Shares Float 10.02 million
- % Held by Insiders 202%
- % Held by Institutions 38.55%
- Shares Short 350477
- Shares Short Prior Month 560497
- Short Ratio 0.6
- Short % of Float 2%
- Short % of Shares Outstanding 2%
View More
Technicals
- Beta 2.01
- 52 Week High $12.2
- 52 Week Low $1.06
- 50 Day Moving Average 9.6
- 200 Day Moving Average 7.62
View More
Dividends
- Dividend Date 2019-11-08
- ExDividend Date N/A
- Dividend Yield 0%
View More
TRACON Pharmaceuticals, Inc (TCON) Dividend Calendar:
TCON's last dividend payment was made to shareholders on November 8, 2019.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
TRACON Pharmaceuticals, Inc (TCON) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-25 | $N/A | -$0.18 | -$0.32 | 44.19% |
| 2020-09-30 | 2020-11-10 | $N/A | -$0.38 | -$0.66 | 42.64% |
| 2020-06-30 | 2020-08-05 | $N/A | -$0.70 | -$0.73 | 3.67% |
| 2020-03-31 | 2020-05-13 | $N/A | -$0.78 | -$1.13 | 31.13% |
| 2019-12-31 | 2020-02-27 | $N/A | -$1.25 | -$1.77 | 29.38% |
| 2019-09-30 | 2019-11-05 | $N/A | -$1.70 | -$2.05 | 17.07% |
| 2019-06-30 | 2019-08-07 | $N/A | -$2.10 | -$1.90 | -10.53% |
| 2019-03-31 | 2019-05-14 | $N/A | -$2.40 | -$2.10 | -14.29% |
| 2018-12-31 | 2019-02-28 | $3 million | -$2.60 | -$3.40 | 23.53% |
| 2018-09-30 | 2018-11-07 | $N/A | -$3.00 | -$2.83 | -6.19% |
| 2018-06-30 | 2018-08-08 | $-3000000 | -$3.30 | -$3.08 | -7.32% |
| 2018-03-31 | 2018-05-09 | $3 million | -$4.60 | -$3.60 | -27.78% |
| 2017-12-31 | 2018-02-28 | $1.26 million | -$3.70 | -$4.77 | 22.38% |
| 2017-09-30 | 2017-11-07 | $7.5 million | $0.70 | -$2.40 | 129.17% |
| 2017-06-30 | 2017-08-08 | $631000 | -$4.00 | -$5.35 | 25.23% |
| 2017-03-31 | 2017-05-10 | $626000 | -$4.40 | -$4.80 | 8.33% |
| 2016-12-31 | 2017-02-28 | $617000 | -$4.50 | -$5.33 | 15.49% |
| 2016-09-30 | 2016-11-08 | $815000 | -$4.80 | -$6.70 | 28.36% |
| 2016-06-30 | 2016-08-11 | $807000 | -$6.80 | -$6.60 | -3.03% |
| 2016-03-31 | 2016-05-11 | $1.21 million | -$5.40 | -$7.60 | 28.95% |
| 2015-12-31 | 2016-02-18 | $1.4 million | -$9.10 | -$6.65 | -36.84% |
| 2015-09-30 | 2015-11-03 | $1.18 million | -$0.53 | -$0.51 | -3.92% |
| 2015-06-30 | 2015-08-05 | $4.2 million | -$0.24 | -$0.39 | 38.46% |
| 2015-03-31 | 2015-05-13 | $1.13 million | -$0.50 | -$0.21 | -138.1% |
| 2014-12-31 | 2015-01-29 | $1.04 million | -$1.64 | -$1.10 | -49.09% |
TRACON Pharmaceuticals, Inc (TCON) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
TRACON Pharmaceuticals, Inc (TCON) Chart:
TRACON Pharmaceuticals, Inc (TCON) News:
Below you will find a list of latest news for TRACON Pharmaceuticals, Inc (TCON) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
TRACON Pharmaceuticals, Inc (TCON) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Latest TCON Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:08 PM EST | 500 | $1.33 |
| Jun 13, 2022 7:17 PM EST | 7 | $1.33 |
| Jun 13, 2022 1:51 PM EST | 100 | $1.41 |
TRACON Pharmaceuticals, Inc (TCON) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-30 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1394319/000156459020031309/0001564590-20-031309-index.htm |
| 2018-05-17 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1394319/000000000018015327/0000000000-18-015327-index.htm |
| 2019-08-29 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1394319/000000000019012971/0000000000-19-012971-index.htm |
| 2019-09-12 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1394319/000000000019013508/0000000000-19-013508-index.htm |
| 2019-11-20 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1394319/000000000019015693/0000000000-19-015693-index.htm |
| 2020-07-07 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1394319/000000000020006069/0000000000-20-006069-index.htm |
| 2020-09-10 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1394319/000000000020008501/0000000000-20-008501-index.htm |
| 2020-09-14 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000089924320025027/0000899243-20-025027-index.htm |
| 2020-09-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000089924320025195/0000899243-20-025195-index.htm |
| 2020-09-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000089924320025617/0000899243-20-025617-index.htm |
| 2020-09-17 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000089924320025618/0000899243-20-025618-index.htm |
| 2018-05-10 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1394319/000095012318004501/0000950123-18-004501-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1394319/000101359419000169/0001013594-19-000169-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1394319/000101359420000128/0001013594-20-000128-index.htm |
| 2019-04-26 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1394319/000110580619000016/0001105806-19-000016-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1394319/000114420419007252/0001144204-19-007252-index.htm |
| 2018-09-07 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1394319/000119312518268455/0001193125-18-268455-index.htm |
| 2019-01-29 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1394319/000119312519020487/0001193125-19-020487-index.htm |
| 2020-01-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1394319/000119312520007171/0001193125-20-007171-index.htm |
| 2020-09-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1394319/000119312520245272/0001193125-20-245272-index.htm |
| 2018-05-30 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000120919118034282/0001209191-18-034282-index.htm |
| 2018-05-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000120919118034284/0001209191-18-034284-index.htm |
| 2018-06-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000120919118037606/0001209191-18-037606-index.htm |
| 2018-06-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000120919118037608/0001209191-18-037608-index.htm |
| 2018-06-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000120919118037609/0001209191-18-037609-index.htm |
| 2018-06-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000120919118037610/0001209191-18-037610-index.htm |
| 2018-06-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000120919118037612/0001209191-18-037612-index.htm |
| 2018-06-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000120919118037613/0001209191-18-037613-index.htm |
| 2018-12-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000120919118063993/0001209191-18-063993-index.htm |
| 2019-01-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000120919119004987/0001209191-19-004987-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000120919119037341/0001209191-19-037341-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000120919119037342/0001209191-19-037342-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000120919119037343/0001209191-19-037343-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000120919119037344/0001209191-19-037344-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000120919119037356/0001209191-19-037356-index.htm |
| 2019-08-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000120919119045450/0001209191-19-045450-index.htm |
| 2019-09-30 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000120919119051151/0001209191-19-051151-index.htm |
| 2020-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000120919120004805/0001209191-20-004805-index.htm |
| 2020-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000120919120004806/0001209191-20-004806-index.htm |
| 2020-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000120919120004808/0001209191-20-004808-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000120919120006280/0001209191-20-006280-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000120919120006283/0001209191-20-006283-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000120919120006286/0001209191-20-006286-index.htm |
| 2020-03-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000120919120017824/0001209191-20-017824-index.htm |
| 2020-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000120919120018516/0001209191-20-018516-index.htm |
| 2020-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000120919120019015/0001209191-20-019015-index.htm |
| 2020-03-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000120919120020001/0001209191-20-020001-index.htm |
| 2020-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000120919120020002/0001209191-20-020002-index.htm |
| 2020-05-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000120919120032058/0001209191-20-032058-index.htm |
| 2020-06-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000120919120037018/0001209191-20-037018-index.htm |
| 2020-06-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000120919120037019/0001209191-20-037019-index.htm |
| 2020-06-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000120919120037020/0001209191-20-037020-index.htm |
| 2020-06-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000120919120037023/0001209191-20-037023-index.htm |
| 2020-06-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000120919120037024/0001209191-20-037024-index.htm |
| 2020-06-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000120919120037025/0001209191-20-037025-index.htm |
| 2020-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000120919120038961/0001209191-20-038961-index.htm |
| 2020-08-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000120919120046866/0001209191-20-046866-index.htm |
| 2020-08-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000120919120047364/0001209191-20-047364-index.htm |
| 2020-08-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000120919120048026/0001209191-20-048026-index.htm |
| 2020-08-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000120919120048180/0001209191-20-048180-index.htm |
| 2020-09-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000120919120049800/0001209191-20-049800-index.htm |
| 2020-09-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000120919120050257/0001209191-20-050257-index.htm |
| 2020-09-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000120919120052046/0001209191-20-052046-index.htm |
| 2020-10-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000120919120055634/0001209191-20-055634-index.htm |
| 2020-08-31 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000149315220017037/0001493152-20-017037-index.htm |
| 2020-08-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000149315220017039/0001493152-20-017039-index.htm |
| 2020-09-01 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1394319/000149315220017042/0001493152-20-017042-index.htm |
| 2020-09-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000149315220017247/0001493152-20-017247-index.htm |
| 2020-09-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000149315220017505/0001493152-20-017505-index.htm |
| 2020-09-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000149315220018389/0001493152-20-018389-index.htm |
| 2020-10-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000149315220019905/0001493152-20-019905-index.htm |
| 2018-05-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459018010781/0001564590-18-010781-index.htm |
| 2018-05-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459018012422/0001564590-18-012422-index.htm |
| 2018-05-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1394319/000156459018012554/0001564590-18-012554-index.htm |
| 2018-05-17 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1394319/000156459018013864/0001564590-18-013864-index.htm |
| 2018-05-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459018014083/0001564590-18-014083-index.htm |
| 2018-05-21 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1394319/000156459018014100/0001564590-18-014100-index.htm |
| 2018-06-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459018015546/0001564590-18-015546-index.htm |
| 2018-06-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459018015703/0001564590-18-015703-index.htm |
| 2018-07-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459018016710/0001564590-18-016710-index.htm |
| 2018-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459018020469/0001564590-18-020469-index.htm |
| 2018-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1394319/000156459018020565/0001564590-18-020565-index.htm |
| 2018-09-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459018022791/0001564590-18-022791-index.htm |
| 2018-11-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459018027997/0001564590-18-027997-index.htm |
| 2018-11-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1394319/000156459018028124/0001564590-18-028124-index.htm |
| 2018-12-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459018030495/0001564590-18-030495-index.htm |
| 2018-12-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459018031301/0001564590-18-031301-index.htm |
| 2019-01-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459019000188/0001564590-19-000188-index.htm |
| 2019-02-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459019005459/0001564590-19-005459-index.htm |
| 2019-03-01 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1394319/000156459019005597/0001564590-19-005597-index.htm |
| 2019-03-01 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1394319/000156459019005606/0001564590-19-005606-index.htm |
| 2019-03-01 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1394319/000156459019005614/0001564590-19-005614-index.htm |
| 2019-04-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459019011153/0001564590-19-011153-index.htm |
| 2019-04-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459019011445/0001564590-19-011445-index.htm |
| 2019-04-25 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1394319/000156459019013035/0001564590-19-013035-index.htm |
| 2019-04-25 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1394319/000156459019013042/0001564590-19-013042-index.htm |
| 2019-05-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459019019145/0001564590-19-019145-index.htm |
| 2019-05-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1394319/000156459019019185/0001564590-19-019185-index.htm |
| 2019-05-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459019021247/0001564590-19-021247-index.htm |
| 2019-06-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459019022574/0001564590-19-022574-index.htm |
| 2019-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459019030072/0001564590-19-030072-index.htm |
| 2019-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1394319/000156459019030194/0001564590-19-030194-index.htm |
| 2019-08-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459019032482/0001564590-19-032482-index.htm |
| 2019-08-28 | S-3/A | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1394319/000156459019033350/0001564590-19-033350-index.htm |
| 2019-09-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459019034269/0001564590-19-034269-index.htm |
| 2019-09-06 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1394319/000156459019034274/0001564590-19-034274-index.htm |
| 2019-09-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459019035127/0001564590-19-035127-index.htm |
| 2019-10-03 | S-3/A | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1394319/000156459019036396/0001564590-19-036396-index.htm |
| 2019-10-03 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1394319/000156459019036401/0001564590-19-036401-index.htm |
| 2019-10-04 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1394319/000156459019036508/0001564590-19-036508-index.htm |
| 2019-10-10 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1394319/000156459019036788/0001564590-19-036788-index.htm |
| 2019-10-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459019037044/0001564590-19-037044-index.htm |
| 2019-10-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459019037188/0001564590-19-037188-index.htm |
| 2019-10-22 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1394319/000156459019037396/0001564590-19-037396-index.htm |
| 2019-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459019040386/0001564590-19-040386-index.htm |
| 2019-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1394319/000156459019040469/0001564590-19-040469-index.htm |
| 2019-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459019041123/0001564590-19-041123-index.htm |
| 2019-11-12 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1394319/000156459019042981/0001564590-19-042981-index.htm |
| 2019-11-20 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1394319/000156459019043989/0001564590-19-043989-index.htm |
| 2019-11-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459019044380/0001564590-19-044380-index.htm |
| 2019-11-25 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1394319/000156459019044388/0001564590-19-044388-index.htm |
| 2019-12-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459019046446/0001564590-19-046446-index.htm |
| 2020-01-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459020000223/0001564590-20-000223-index.htm |
| 2020-01-13 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1394319/000156459020000888/0001564590-20-000888-index.htm |
| 2020-01-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459020000904/0001564590-20-000904-index.htm |
| 2020-02-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459020003793/0001564590-20-003793-index.htm |
| 2020-02-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459020003956/0001564590-20-003956-index.htm |
| 2020-02-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459020007380/0001564590-20-007380-index.htm |
| 2020-02-28 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1394319/000156459020007520/0001564590-20-007520-index.htm |
| 2020-02-28 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1394319/000156459020007525/0001564590-20-007525-index.htm |
| 2020-02-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459020007528/0001564590-20-007528-index.htm |
| 2020-02-28 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1394319/000156459020007534/0001564590-20-007534-index.htm |
| 2020-03-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459020009472/0001564590-20-009472-index.htm |
| 2020-03-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459020010817/0001564590-20-010817-index.htm |
| 2020-03-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459020011711/0001564590-20-011711-index.htm |
| 2020-04-14 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1394319/000156459020016724/0001564590-20-016724-index.htm |
| 2020-04-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459020016899/0001564590-20-016899-index.htm |
| 2020-04-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459020018348/0001564590-20-018348-index.htm |
| 2020-04-24 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1394319/000156459020018541/0001564590-20-018541-index.htm |
| 2020-04-24 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1394319/000156459020018548/0001564590-20-018548-index.htm |
| 2020-05-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459020020856/0001564590-20-020856-index.htm |
| 2020-05-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459020025060/0001564590-20-025060-index.htm |
| 2020-05-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1394319/000156459020025138/0001564590-20-025138-index.htm |
| 2020-05-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459020025280/0001564590-20-025280-index.htm |
| 2020-06-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459020029017/0001564590-20-029017-index.htm |
| 2020-06-30 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1394319/000156459020031309/0001564590-20-031309-index.htm |
| 2020-07-07 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1394319/000156459020031957/0001564590-20-031957-index.htm |
| 2020-08-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459020036815/0001564590-20-036815-index.htm |
| 2020-08-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1394319/000156459020036948/0001564590-20-036948-index.htm |
| 2020-08-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459020041441/0001564590-20-041441-index.htm |
| 2020-08-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459020041892/0001564590-20-041892-index.htm |
| 2020-09-04 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1394319/000156459020042569/0001564590-20-042569-index.htm |
| 2020-09-09 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1394319/000156459020042940/0001564590-20-042940-index.htm |
| 2020-09-16 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1394319/000156459020043719/0001564590-20-043719-index.htm |
| 2020-09-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1394319/000156459020044052/0001564590-20-044052-index.htm |
| 2020-10-20 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1394319/000156459020046958/0001564590-20-046958-index.htm |
| 2020-10-30 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1394319/000156459020049320/0001564590-20-049320-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1394319/000158064219000789/0001580642-19-000789-index.htm |
| 2018-12-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000173343918000015/0001733439-18-000015-index.htm |
| 2018-12-03 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000173343918000016/0001733439-18-000016-index.htm |
| 2019-12-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1394319/000173343919000001/0001733439-19-000001-index.htm |
| 2020-02-14 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1394319/000173343920000001/0001733439-20-000001-index.htm |
| 2018-05-21 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1394319/999999999518001298/9999999995-18-001298-index.htm |
| 2019-10-08 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1394319/999999999519002270/9999999995-19-002270-index.htm |
| 2019-11-22 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1394319/999999999519002651/9999999995-19-002651-index.htm |
| 2020-07-09 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1394319/999999999520001750/9999999995-20-001750-index.htm |
| 2020-09-11 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1394319/999999999520002428/9999999995-20-002428-index.htm |
| 2019-04-15 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1394319/999999999719002895/9999999997-19-002895-index.htm |
| 2019-09-11 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1394319/999999999719006774/9999999997-19-006774-index.htm |
| 2019-09-11 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1394319/999999999719006775/9999999997-19-006775-index.htm |
| 2020-08-03 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1394319/999999999720004262/9999999997-20-004262-index.htm |
TRACON Pharmaceuticals, Inc (TCON) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of TRACON Pharmaceuticals, Inc (TCON). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 202%Institutional Ownership: 3855%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-08-27 | Opaleye Management Inc. | 10% Share Holder | Buy | 35,408.00 | 1.71 | 60,434.37 | 1,206,196.00 | https://www.sec.gov/Archives/edgar/data/1394319/000149315220017039/0001493152-20-017039-index.htm |
| 2020-09-10 | MARK C WIGGINS | Chief Business Officer | Buy | 7,000.00 | 4.14 | 28,952.70 | 12,350.00 | https://www.sec.gov/Archives/edgar/data/1394319/000120919120050257/0001209191-20-050257-index.htm |
| 2018-12-21 | CHARLES THEUER | President and CEO | Buy | 49,000.00 | 0.66 | 32,222.40 | 132,855.00 | https://www.sec.gov/Archives/edgar/data/1394319/000120919118063993/0001209191-18-063993-index.htm |
| 2020-08-31 | Opaleye Management Inc. | 10% Share Holder | Buy | 146,150.00 | 1.67 | 244,070.50 | 1,352,346.00 | https://www.sec.gov/Archives/edgar/data/1394319/000149315220017039/0001493152-20-017039-index.htm |
| 2020-08-18 | CHARLES THEUER | President and CEO | Buy | 44,743.00 | 1.63 | 72,850.55 | 136,557.00 | https://www.sec.gov/Archives/edgar/data/1394319/000120919120047364/0001209191-20-047364-index.htm |
| 2020-08-27 | Opaleye Management Inc. | 10% Share Holder | Buy | 147,946.00 | 1.71 | 252,514.23 | 150,000.00 | https://www.sec.gov/Archives/edgar/data/1394319/000149315220017039/0001493152-20-017039-index.htm |
| 2020-08-31 | Opaleye Management Inc. | 10% Share Holder | Buy | 150,000.00 | 1.84 | 275,370.00 | 1,502,346.00 | https://www.sec.gov/Archives/edgar/data/1394319/000149315220017039/0001493152-20-017039-index.htm |
| 2020-09-01 | Opaleye Management Inc. | 10% Share Holder | Buy | 38,600.00 | 2.04 | 78,906.12 | 1,540,946.00 | https://www.sec.gov/Archives/edgar/data/1394319/000149315220017247/0001493152-20-017247-index.htm |
| 2020-09-02 | Opaleye Management Inc. | 10% Share Holder | Buy | 115,000.00 | 2.35 | 270,756.00 | 1,655,946.00 | https://www.sec.gov/Archives/edgar/data/1394319/000149315220017247/0001493152-20-017247-index.htm |
| 2020-09-04 | Opaleye Management Inc. | 10% Share Holder | Buy | 8,492.00 | 2.88 | 24,496.87 | 1,664,438.00 | https://www.sec.gov/Archives/edgar/data/1394319/000149315220017505/0001493152-20-017505-index.htm |
| 2020-08-20 | CHARLES THEUER | President and CEO | Buy | 30,000.00 | 1.58 | 47,400.00 | 166,557.00 | https://www.sec.gov/Archives/edgar/data/1394319/000120919120048026/0001209191-20-048026-index.htm |
| 2020-09-09 | Opaleye Management Inc. | 10% Share Holder | Buy | 45,000.00 | 3.47 | 156,100.50 | 1,709,438.00 | https://www.sec.gov/Archives/edgar/data/1394319/000149315220017505/0001493152-20-017505-index.htm |
| 2020-08-21 | CHARLES THEUER | President and CEO | Buy | 5,325.00 | 1.56 | 8,307.00 | 171,882.00 | https://www.sec.gov/Archives/edgar/data/1394319/000120919120048180/0001209191-20-048180-index.htm |
| 2019-08-09 | CHARLES THEUER | President and CEO | Buy | 50,000.00 | 0.45 | 22,500.00 | 173,565.00 | https://www.sec.gov/Archives/edgar/data/1394319/000120919119045450/0001209191-19-045450-index.htm |
| 2020-09-23 | Opaleye Management Inc. | 10% Share Holder | Buy | 55,000.00 | 4.83 | 265,815.00 | 1,764,438.00 | https://www.sec.gov/Archives/edgar/data/1394319/000149315220018389/0001493152-20-018389-index.htm |
| 2020-09-04 | CHARLES THEUER | President and CEO | Buy | 5,000.00 | 2.60 | 13,000.00 | 176,882.00 | https://www.sec.gov/Archives/edgar/data/1394319/000120919120049800/0001209191-20-049800-index.htm |
| 2020-09-24 | Opaleye Management Inc. | 10% Share Holder | Buy | 21,000.00 | 4.44 | 93,275.70 | 1,785,438.00 | https://www.sec.gov/Archives/edgar/data/1394319/000149315220018389/0001493152-20-018389-index.htm |
| 2020-10-21 | Opaleye Management Inc. | 10% Share Holder | Buy | 5,656.00 | 4.40 | 24,868.87 | 1,797,094.00 | https://www.sec.gov/Archives/edgar/data/1394319/000149315220019905/0001493152-20-019905-index.htm |
| 2020-09-04 | CHARLES THEUER | President and CEO | Buy | 5,000.00 | 2.55 | 12,750.00 | 181,882.00 | https://www.sec.gov/Archives/edgar/data/1394319/000120919120049800/0001209191-20-049800-index.htm |
| 2020-09-23 | CHARLES THEUER | President and CEO | Buy | 4,893.00 | 4.72 | 23,093.98 | 186,775.00 | https://www.sec.gov/Archives/edgar/data/1394319/000120919120052046/0001209191-20-052046-index.htm |
| 2020-09-23 | CHARLES THEUER | President and CEO | Buy | 107.00 | 4.72 | 505.05 | 186,882.00 | https://www.sec.gov/Archives/edgar/data/1394319/000120919120052046/0001209191-20-052046-index.htm |
| 2020-10-21 | CHARLES THEUER | President and CEO | Buy | 2,000.00 | 4.38 | 8,769.00 | 189,232.00 | https://www.sec.gov/Archives/edgar/data/1394319/000120919120055634/0001209191-20-055634-index.htm |
| 2020-09-04 | Ikarian Capital, LLC | 10% Share Holder | Buy | 151,611.00 | 2.87 | 434,501.96 | 1,991,689.00 | https://www.sec.gov/Archives/edgar/data/1394319/000089924320025195/0000899243-20-025195-index.htm |
| 2020-09-08 | Ikarian Capital, LLC | 10% Share Holder | Buy | 13,244.00 | 2.90 | 38,407.60 | 2,004,933.00 | https://www.sec.gov/Archives/edgar/data/1394319/000089924320025195/0000899243-20-025195-index.htm |
| 2020-09-09 | Ikarian Capital, LLC | 10% Share Holder | Buy | 79,415.00 | 3.49 | 277,460.13 | 2,084,348.00 | https://www.sec.gov/Archives/edgar/data/1394319/000089924320025195/0000899243-20-025195-index.htm |
| 2020-08-28 | Opaleye Management Inc. | 10% Share Holder | Buy | 60,000.00 | 1.78 | 106,974.00 | 210,000.00 | https://www.sec.gov/Archives/edgar/data/1394319/000149315220017039/0001493152-20-017039-index.htm |
| 2020-08-31 | Opaleye Management Inc. | 10% Share Holder | Buy | 6,000.00 | 1.84 | 11,014.80 | 216,000.00 | https://www.sec.gov/Archives/edgar/data/1394319/000149315220017039/0001493152-20-017039-index.htm |
| 2020-09-11 | Ikarian Capital, LLC | 10% Share Holder | Buy | 78,201.00 | 3.93 | 307,017.13 | 2,162,549.00 | https://www.sec.gov/Archives/edgar/data/1394319/000089924320025195/0000899243-20-025195-index.htm |
| 2020-09-01 | Opaleye Management Inc. | 10% Share Holder | Buy | 1,400.00 | 2.04 | 2,861.88 | 217,400.00 | https://www.sec.gov/Archives/edgar/data/1394319/000149315220017247/0001493152-20-017247-index.htm |
| 2020-09-02 | Opaleye Management Inc. | 10% Share Holder | Buy | 4,800.00 | 2.35 | 11,301.12 | 222,200.00 | https://www.sec.gov/Archives/edgar/data/1394319/000149315220017247/0001493152-20-017247-index.htm |
| 2020-09-04 | Opaleye Management Inc. | 10% Share Holder | Buy | 566.00 | 2.88 | 1,632.74 | 222,766.00 | https://www.sec.gov/Archives/edgar/data/1394319/000149315220017505/0001493152-20-017505-index.htm |
| 2020-10-21 | Opaleye Management Inc. | 10% Share Holder | Buy | 3,000.00 | 4.40 | 13,190.70 | 225,000.00 | https://www.sec.gov/Archives/edgar/data/1394319/000149315220019905/0001493152-20-019905-index.htm |
| 2020-09-09 | Opaleye Management Inc. | 10% Share Holder | Buy | 2,500.00 | 3.47 | 8,672.25 | 225,266.00 | https://www.sec.gov/Archives/edgar/data/1394319/000149315220017505/0001493152-20-017505-index.htm |
| 2020-09-23 | Opaleye Management Inc. | 10% Share Holder | Buy | 2,200.00 | 4.83 | 10,632.60 | 227,466.00 | https://www.sec.gov/Archives/edgar/data/1394319/000149315220018389/0001493152-20-018389-index.htm |
| 2020-09-24 | Opaleye Management Inc. | 10% Share Holder | Buy | 534.00 | 4.44 | 2,371.87 | 228,000.00 | https://www.sec.gov/Archives/edgar/data/1394319/000149315220018389/0001493152-20-018389-index.htm |
| 2020-06-11 | SAUNDRA L PELLETIER | Director | Buy | 2,500.00 | 2.00 | 5,000.00 | 2,500.00 | https://www.sec.gov/Archives/edgar/data/1394319/000120919120037018/0001209191-20-037018-index.htm |
| 2020-03-10 | CHARLES THEUER | President and CEO | Buy | 10,000.00 | 1.87 | 18,691.00 | 26,777.00 | https://www.sec.gov/Archives/edgar/data/1394319/000120919120017824/0001209191-20-017824-index.htm |
| 2020-03-11 | CHARLES THEUER | President and CEO | Buy | 5,000.00 | 1.71 | 8,549.00 | 31,777.00 | https://www.sec.gov/Archives/edgar/data/1394319/000120919120018516/0001209191-20-018516-index.htm |
| 2020-03-11 | CHARLES THEUER | President and CEO | Buy | 5,000.00 | 1.66 | 8,287.50 | 36,777.00 | https://www.sec.gov/Archives/edgar/data/1394319/000120919120018516/0001209191-20-018516-index.htm |
| 2019-12-05 | Puissance Cross-Border Opportunities V LLC | 10% Share Holder | Sell | 43,996.00 | 3.05 | 134,187.80 | 416,182.00 | https://www.sec.gov/Archives/edgar/data/1394319/000173343919000001/0001733439-19-000001-index.htm |
| 2020-03-12 | CHARLES THEUER | President and CEO | Buy | 5,000.00 | 1.19 | 5,944.50 | 41,777.00 | https://www.sec.gov/Archives/edgar/data/1394319/000120919120018516/0001209191-20-018516-index.htm |
| 2018-11-29 | Puissance Cross-Border Opportunities V LLC | 10% Share Holder | Sell | 4,326.00 | 1.21 | 5,234.46 | 4,601,768.00 | https://www.sec.gov/Archives/edgar/data/1394319/000173343918000015/0001733439-18-000015-index.htm |
| 2018-11-29 | Puissance Cross-Border Opportunities V LLC | 10% Share Holder | Buy | 4,326.00 | 1.13 | 4,888.38 | 4,606,094.00 | https://www.sec.gov/Archives/edgar/data/1394319/000173343918000015/0001733439-18-000015-index.htm |
| 2020-03-12 | CHARLES THEUER | President and CEO | Buy | 5,000.00 | 1.17 | 5,858.00 | 46,777.00 | https://www.sec.gov/Archives/edgar/data/1394319/000120919120018516/0001209191-20-018516-index.htm |
| 2020-01-23 | MARK C WIGGINS | Chief Business Officer | Buy | 5,000.00 | 4.02 | 20,102.50 | 5,000.00 | https://www.sec.gov/Archives/edgar/data/1394319/000120919120004808/0001209191-20-004808-index.htm |
| 2020-03-13 | CHARLES THEUER | President and CEO | Buy | 4,100.00 | 1.13 | 4,624.39 | 50,877.00 | https://www.sec.gov/Archives/edgar/data/1394319/000120919120019015/0001209191-20-019015-index.htm |
| 2020-06-15 | SAUNDRA L PELLETIER | Director | Buy | 3,000.00 | 2.07 | 6,209.10 | 5,500.00 | https://www.sec.gov/Archives/edgar/data/1394319/000120919120037018/0001209191-20-037018-index.htm |
| 2020-05-22 | CHARLES THEUER | President and CEO | Buy | 10,000.00 | 1.90 | 19,000.00 | 61,227.00 | https://www.sec.gov/Archives/edgar/data/1394319/000120919120032058/0001209191-20-032058-index.htm |
| 2020-05-22 | CHARLES THEUER | President and CEO | Buy | 592.00 | 1.89 | 1,118.88 | 61,819.00 | https://www.sec.gov/Archives/edgar/data/1394319/000120919120032058/0001209191-20-032058-index.htm |
| 2020-06-24 | CHARLES THEUER | President and CEO | Buy | 9,895.00 | 1.90 | 18,800.50 | 71,714.00 | https://www.sec.gov/Archives/edgar/data/1394319/000120919120038961/0001209191-20-038961-index.htm |
| 2019-12-09 | Puissance Cross-Border Opportunities V LLC | 10% Share Holder | Sell | 340,134.00 | 2.92 | 993,191.28 | 76,048.00 | https://www.sec.gov/Archives/edgar/data/1394319/000173343919000001/0001733439-19-000001-index.htm |
| 2020-08-12 | CHARLES THEUER | President and CEO | Buy | 5,000.00 | 1.67 | 8,350.00 | 76,714.00 | https://www.sec.gov/Archives/edgar/data/1394319/000120919120046866/0001209191-20-046866-index.htm |
| 2020-08-12 | CHARLES THEUER | President and CEO | Buy | 10,000.00 | 1.79 | 17,900.00 | 86,714.00 | https://www.sec.gov/Archives/edgar/data/1394319/000120919120046866/0001209191-20-046866-index.htm |
| 2020-08-13 | CHARLES THEUER | President and CEO | Buy | 5,000.00 | 1.65 | 8,250.00 | 91,714.00 | https://www.sec.gov/Archives/edgar/data/1394319/000120919120046866/0001209191-20-046866-index.htm |
| 2020-08-14 | CHARLES THEUER | President and CEO | Buy | 100.00 | 1.70 | 170.15 | 91,814.00 | https://www.sec.gov/Archives/edgar/data/1394319/000120919120047364/0001209191-20-047364-index.htm |